Clinical Trial Update: Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the effects of Lovaza on lipoprotein composition and function in mild hypertriglyceridemia (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: Sanford Research | Conditions: Hypertriglyceridemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-20